Neuralink Dives into Human Trials
Elon Musk’s Neuralink lifts the recruitment curtain for its audacious first-in-human clinical trial. The groundbreaking PRIME Study endeavors to implant a brain-computer interface, a revolutionary technology aimed to aid those battling severe degenerative diseases. By surgically implanting ‘N1 Implant’ within the brain’s movement control areas, it seeks to enable computer manipulation using brain signals alone. Despite treading a rocky pathway to human trials due to safety worries raised by FDA, Neuralink continues to unfalteringly chase this medical marvel. As accusations cloud Neuralink’s operations, the scientific community awaits the unfolding of this monumental neurotechnology endeavor.